论文部分内容阅读
目的：探讨提高Ⅰ、Ⅱ期咽淋巴环非何杰金林巴瘤疗效的治疗方式。方法：回顾性分析Ⅰ、Ⅱ期咽淋巴环非何杰金淋巴瘤139例。分为单纯放疗，放疗加化疗（1～3周期），放疗加化疗（4～6周期）三组，比较治疗结果。结果：Ⅰ期三种治疗方式的5年生存率分别为72．2％、43．7％和66.7％。统计学处理无差异（P＞0.05）。Ⅱ期放疗加化疗4～6周期优于放疗加化疗1～3周期（P＜0．05），优于单纯放疗P＜0．61），5年生存率分别为64.0%、35.6％和26.9％。结论：Ⅰ期以放疗为主，Ⅱ期行放疗加化疗（4～6周期）的综合治疗能提高疗效。
Objective: To explore the ways to improve the curative effect of non-Hodgkin’s lymphoma in phase Ⅰ and Ⅱ pharyngeal lymph nodes. Methods: A retrospective analysis of 139 cases of non-Hodgkin’s lymphoma of phase Ⅰ and Ⅱ pharyngeal lymph nodes. Divided into simple radiotherapy, radiotherapy plus chemotherapy (1 to 3 cycles), radiotherapy plus chemotherapy (4 to 6 cycles) three groups, the treatment of the results. Results: The five-year survival rates of the three treatment methods were 72.2%, 43.7% and 66.7% respectively. No statistical difference (P> 0.05). The 2-stage radiotherapy plus chemotherapy 4 to 6 cycles was superior to radiotherapy plus chemotherapy 1 to 3 cycles (P <0.05), which was better than radiotherapy alone (P <0.61). The 5-year survival rates were 64.0%, 35.6% and 26.9 %. Conclusion: The first stage is radiotherapy, and the second stage radiotherapy plus chemotherapy (4-6 cycles) can improve the curative effect.